DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Hetero Labs Limited
03 1Indena SpA
04 1MSN Laboratories Private Limited
05 1Sichuan Xieli Pharmaceutical Co., Ltd.
06 1TAPI Czech Industries s.r.o.
07 1Teva Czech Industries s.r.o
08 1Yung Shin Pharm. Ind. Co., Ltd.
01 8Cabazitaxel
01 1China
02 3India
03 1Israel
04 1Italy
05 1Taiwan
06 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-962
Start Marketing Date : 2014-02-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0080
Start Marketing Date : 2010-06-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17359-1700
Start Marketing Date : 2019-02-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0016
Start Marketing Date : 2010-06-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61200-101
Start Marketing Date : 2015-05-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 47848-044
Start Marketing Date : 2013-01-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63126-909
Start Marketing Date : 2020-12-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84644-044
Start Marketing Date : 2013-01-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
15
PharmaCompass offers a list of Cabazitaxel API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cabazitaxel manufacturer or Cabazitaxel supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cabazitaxel manufacturer or Cabazitaxel supplier.
PharmaCompass also assists you with knowing the Cabazitaxel API Price utilized in the formulation of products. Cabazitaxel API Price is not always fixed or binding as the Cabazitaxel Price is obtained through a variety of data sources. The Cabazitaxel Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A RPR 116258A manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RPR 116258A, including repackagers and relabelers. The FDA regulates RPR 116258A manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RPR 116258A API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of RPR 116258A manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A RPR 116258A supplier is an individual or a company that provides RPR 116258A active pharmaceutical ingredient (API) or RPR 116258A finished formulations upon request. The RPR 116258A suppliers may include RPR 116258A API manufacturers, exporters, distributors and traders.
click here to find a list of RPR 116258A suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing RPR 116258A as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for RPR 116258A API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture RPR 116258A as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain RPR 116258A and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a RPR 116258A NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of RPR 116258A suppliers with NDC on PharmaCompass.
We have 7 companies offering RPR 116258A
Get in contact with the supplier of your choice:
